Headquarters Country
Headquarters Continent
World Rank (Jan-07-2022)
27
Market Value (Jan-07-2022)
312.75 Billion USD
World Rank (Sep-01-2021)
36
Market Cap (Sep-01-2021)
258.30 Billion USD
World Rank (Jan-01-2021)
46
Market Value (Jan-01-2021)
204.60 Billion USD
World Rank (Jan-2020)
37
Market Value (Jan 1st 2020)
215.48 Billion USD
Annual Revenue in USD
81,288 Million USD
Annual Net Income in USD
21,980 Million USD
Annual Results for Year Ending
Dec-2021
Total Assets in USD
154,230 Million USD
Total Equity in USD
63,238 Million USD
Total Liabilities in USD
90,991 Million USD
Balance Sheet Summary for Period ending
Dec-2020
Headquarters Region / City
Stock Category
World Sub Region
Rank in Country (Jan-2020)
Rank in USA in 2020 is 25
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 29
Company Business
Number of Employees
78,500
Employee Count as on Date
As on May 2021
CEO:
Founders
Founded Year
1849
Stock Exchange
Company Website:
Pfizer is expanding Phase 3 Trials to test Covid-19 Vaccine
Pfizer and BioNTech planning to expand phase 3 trials to test Covid-19 vaccine. From initial plan of 30,000 people, now they are planning to conduct trials of Covid-19 vaccine on 44,000 people. They are expecting results by Oct-2020 ending.